UM  > 社會科學學院
Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders
Geoffrey M. Reed1,2; Michael B. First2,3; Cary S. Kogan4; Steven E. Hyman5; Oye Gureje6; Wolfgang Gaebel7; Mario Maj8; Dan J. Stein9; Andreas Maercker10; Peter Tyrer11; Angelica Claudino12; Elena Garralda11; Luis Salvador‐Carulla13; Rajat Ray14; John B. Saunders15; Tarun Dua1; Vladimir Poznyak1; María Elena Medina‐Mora16; Kathleen M. Pike2; José L. Ayuso‐Mateos17; Shigenobu Kanba18; Jared W. Keeley19; Brigitte Khoury20; Valery N. Krasnov21; Maya Kulygina21; Anne M. Lovell22; Jair de Jesus Mari12; Toshimasa Maruta23; Chihiro Matsumoto24; Tahilia J. Rebello2,3; Michael C. Roberts25; Rebeca Robles16; Pratap Sharan26; Min Zhao27; Assen Jablensky28; Pichet Udomratn29; Afarin Rahimi‐Movaghar30; Per‐Anders Rydelius31; Sabine Bährer‐Kohler32; Ann D. Watts33; Shekhar Saxena34
2019
Source PublicationWorld Psychiatry
ISSN1723-8617
Volume18Issue:1Pages:3-19
Abstract

Following approval of the ICD-11 by the World Health Assembly in May 2019, World Health Organization (WHO) member states will transi-tion from the ICD-10 to the ICD-11, with reporting of health statistics based on the new system to begin on January 1, 2022. The WHO Department of Mental Health and Substance Abuse will publish Clinical Descriptions and Diagnostic Guidelines (CDDG) for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders following ICD-11’s approval. The development of the ICD-11 CDDG over the past decade, based on the principles of clinical utility and global applicability, has been the most broadly international, multilingual, multidisciplinary and participative revision process ever implemented for a classification of mental disorders. Innovations in the ICD-11 include the provision of consistent and systematically characterized information, the adoption of a lifespan approach, and culture-related guidance for each disorder. Dimensional approaches have been incorporated into the classification, particularly for personality disorders and primary psychotic disorders, in ways that are consistent with current evidence, are more compatible with recovery-based approaches, eliminate artificial comorbidity, and more effectively capture changes over time. Here we describe major changes to the structure of the ICD-11 classification of mental disorders as compared to the ICD-10, and the development of two new ICD-11 chapters relevant to mental health practice. We illustrate a set of new categories that have been added to the ICD-11 and present the rationale for their inclusion. Finally, we provide a description of the important changes that have been made in each ICD-11 disorder grouping. This information is intended to be useful for both clinicians and researchers in orienting themselves to the ICD-11 and in preparing for implementation in their own professional contexts.

KeywordInternational Classification Of Diseases, Icd-11, Diagnosis, Mental Disorders, Clinical Utility, Dimensional Approaches, Culture-related Guidance
Indexed BySSCI
Language英语
WOS Research AreaPsychiatry
WOS SubjectPsychiatry
WOS IDWOS:000454694100002
PublisherWILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionFaculty of Social Sciences
Affiliation1.Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland
2.Department of Psychiatry, Columbia University Medical Center, New York, NY, USA
3.New York State Psychiatric Institute, New York, NY, USA
4.School of Psychology, University of Ottawa, Ottawa, ON, Canada;
5.Stanley Center for Psychiatric Research, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA
6.Department of Psychiatry, University of Ibadan, Ibadan, Nigeria;
7.Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany;
8.Department of Psychiatry, University of Campania “L. Vanvitelli”, Naples, Italy;
9.Department of Psychiatry, University of Cape Town, and South African Medical Research Council Unit on Risk and Resilience in Mental Disorders, Cape Town, South Africa;
10.Department of Psychology, University of Zurich, Zurich, Switzerland
11.Centre for Mental Health, Imperial College, London, UK
12.Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP/EPM), São Paulo, Brazil
13.Research School of Population Health, Australian National University, Canberra, ACT, Australia
14.National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India
15.Centre for Youth Substance Abuse Research, University of Queensland, Brisbane, QLD, Australia
16.National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico
17.Department of Psychiatry, Universidad Autonoma de Madrid; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); Instituto de Investigación Sanitaria La Princesa, Madrid, Spain
18.Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan
19.Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA
20.Department of Psychiatry, American University of Beirut Medical Center, Beirut, Lebanon
21.Moscow Research Institute of Psychiatry, National Medical Research Centre for Psychiatry and Narcology, Moscow, Russian Federation
22.Institut National de la Santé et de la Recherche Médicale U988, Paris, France
23.Health Management Center, Seitoku University, Matsudo, Japan
24.Japanese Society of Psychiatry and Neurology, Tokyo, Japan
25.Office of Graduate Studies and Clinical Child Psychology Program, University of Kansas, Lawrence, KS, USA
26.Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India
27.Shanghai Mental Health Center and Department of Psychiatry, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
28.Centre for Clinical Research in Neuropsychiatry, University of Western Australia, Perth, WA, Australia
29.Department of Psychiatry, Prince of Songkla University, Hat Yai, Thailand
30.Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
31.Department of Child and Adolescent Psychiatry, Karolinska Institute, Stockholm, Sweden
32.International Federation of Social Workers, Basel, Switzerland
33.Entabeni Hospital, Durban, South Africa
34.Harvard T.H. Chan School of Public Health, Boston, MA, USA
Recommended Citation
GB/T 7714
Geoffrey M. Reed,Michael B. First,Cary S. Kogan,et al. Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders[J]. World Psychiatry,2019,18(1):3-19.
APA Geoffrey M. Reed.,Michael B. First.,Cary S. Kogan.,Steven E. Hyman.,Oye Gureje.,...&Shekhar Saxena.(2019).Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders.World Psychiatry,18(1),3-19.
MLA Geoffrey M. Reed,et al."Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders".World Psychiatry 18.1(2019):3-19.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Geoffrey M. Reed]'s Articles
[Michael B. First]'s Articles
[Cary S. Kogan]'s Articles
Baidu academic
Similar articles in Baidu academic
[Geoffrey M. Reed]'s Articles
[Michael B. First]'s Articles
[Cary S. Kogan]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Geoffrey M. Reed]'s Articles
[Michael B. First]'s Articles
[Cary S. Kogan]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.